Cue Biopharma, Inc. generated $27.5M in revenue in fiscal year 2025. This represents an increase of 195.7% from the prior fiscal year. Over the trailing 12 months, Q4 FY2025 through Q3 FY2026, the same line adds up to $35.6M in revenue. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters Cue Biopharma, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
CUE Revenue by Fiscal Year
Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.
CUE Revenue by Quarter
Figures are in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More Cue Biopharma, Inc. financials
Frequently Asked Questions
Cue Biopharma, Inc. generated $27.5M in revenue in fiscal year 2025.
Cue Biopharma, Inc. (CUE) revenue rose by 195.7% year over year, from $9.3M to $27.5M in fiscal year 2025.
Cue Biopharma, Inc. (CUE) reported $35.6M in revenue over the trailing 12 months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.
Cue Biopharma, Inc. (CUE) reported $132K in revenue in Q3 2026. This represents a decrease of 93.9% from the same quarter a year earlier.
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Cue Biopharma, Inc. (CUE) reported on that line in every period on record.